1. Home
  2. ROIV vs XP Comparison

ROIV vs XP Comparison

Compare ROIV & XP Stocks: Price Trends, ML Decisions, Charts, Trends, Technical Analysis and more.

  • Machine Learning Prediction
  • ML Decision
  • ROIV
  • XP
  • Stock Information
  • Founded
  • ROIV 2014
  • XP 2001
  • Country
  • ROIV United Kingdom
  • XP Cayman Islands
  • Employees
  • ROIV N/A
  • XP N/A
  • Industry
  • ROIV Biotechnology: Pharmaceutical Preparations
  • XP Investment Bankers/Brokers/Service
  • Sector
  • ROIV Health Care
  • XP Finance
  • Exchange
  • ROIV Nasdaq
  • XP Nasdaq
  • Market Cap
  • ROIV 7.8B
  • XP 9.8B
  • IPO Year
  • ROIV N/A
  • XP 2019
  • Fundamental
  • Price
  • ROIV $10.99
  • XP $19.36
  • Analyst Decision
  • ROIV Buy
  • XP Buy
  • Analyst Count
  • ROIV 4
  • XP 6
  • Target Price
  • ROIV $17.50
  • XP $22.00
  • AVG Volume (30 Days)
  • ROIV 5.1M
  • XP 8.5M
  • Earning Date
  • ROIV 05-29-2025
  • XP 05-20-2025
  • Dividend Yield
  • ROIV N/A
  • XP 3.36%
  • EPS Growth
  • ROIV N/A
  • XP 15.23
  • EPS
  • ROIV N/A
  • XP 1.51
  • Revenue
  • ROIV $29,053,000.00
  • XP $2,886,046,386.00
  • Revenue This Year
  • ROIV N/A
  • XP $19.79
  • Revenue Next Year
  • ROIV N/A
  • XP $12.65
  • P/E Ratio
  • ROIV N/A
  • XP $12.80
  • Revenue Growth
  • ROIV N/A
  • XP 9.27
  • 52 Week Low
  • ROIV $8.73
  • XP $10.82
  • 52 Week High
  • ROIV $13.06
  • XP $20.39
  • Technical
  • Relative Strength Index (RSI)
  • ROIV 52.59
  • XP 74.59
  • Support Level
  • ROIV $10.59
  • XP $18.04
  • Resistance Level
  • ROIV $11.37
  • XP $19.85
  • Average True Range (ATR)
  • ROIV 0.32
  • XP 0.55
  • MACD
  • ROIV -0.01
  • XP -0.00
  • Stochastic Oscillator
  • ROIV 52.23
  • XP 78.00

About ROIV Roivant Sciences Ltd.

Roivant Sciences Ltd is a commercial-stage biopharmaceutical company dedicated to improving the delivery of healthcare to patients. It also incubates discovery-stage companies and health technology startups complementary to its biopharmaceutical business. Its drug candidate VTAMA (tapinarof) is a treatment of plaque psoriasis in adult patients and is in its commercial stage. The other drug candidates in their different stages of development are; Batoclimab, IMVT-1402, Brepocitinib, Namilumab, and others.

About XP XP Inc.

XP Inc is a Cayman Island-based technology-driven financial services platform. It is a provider of low-fee financial products and services in Brazil. The company evaluates its business through a single segment such as monitoring operations, making decisions on fund allocation, and evaluating the performance. It generates revenue through the Brokerage commission.

Share on Social Networks: